Skip to main content

Table 2 Overview of variables measured in this study

From: Effectiveness of behavioural graded activity compared with physiotherapy treatment in chronic neck pain: design of a randomised clinical trial [ISRCTN88733332]

Variable

Time Measured

Range of unit

 

T0

T4

T9

Ts

T26

T52

 

Inclusion and exclusion variables

x

      

Demographic variables

x

      

Baseline variables

       

Specific complaint characteristics

x

      

Experience of the neck complaint and functioning in daily activities

x

     

1–7 (Likert scale)

Co-morbidity

x

      

Additional complaints

x

      

Primary outcome

       

'Global perceived effect' (neck complaint and functioning in daily activities) [31]

 

x

x

x

x

x

1–7 (Likert scale)

Secondary outcomes

       

Main complaint [29]

x

x

x

x

x

x

0–10 (Likert scale)

Pain (VAS) [31]

x

x

x

x

x

x

 

Medical consumption

x

x

x

x

x

x

Dose per day

Coping with Multi-dimensional pain (MPI) Part I-II [32]

x

 

x

 

x

x

0–6 (Likert scale)

Activity (MPI, part III)

x

x

x

x

x

x

0–6 (likert scale)

Specific functional status (NDI) [33]

x

x

x

x

x

x

 

Quality of life (SF-36) [34, 35]

x

 

x

 

x

x

 

(EQ-5d) [35, 36]

x

x

x

x

x

x

 

Work activities

x

 

x

 

x

x

Hours/week

Satisfaction about treatment

 

x

x

x

x

 

1–5 (Likert scale)

Compliance with treatment exercise

 

x

x

x

x

x

Number and time per week

Additional treatments

 

x

x

x

x

x

Discipline and number of treatments

Side-effects

 

x

x

x

x

x

Yes – No and any additional elucidation

Psychological (prognostic) variables

       

Fear of movement (TSK) [37]

x

   

x

x

1–4 (likert scale)

Catastrophizing (PCS) [38]

x

 

x

 

x

 

1–5 (likert scale)

Depression (CES-D) [39]

x

 

x

 

x

 

1–4 (likert scale)

Self-efficacy (PSEQ) [40]

x

x

x

x

x

x

10–100% (very unsure – very sure)

Stages of change (PSOCQ) [41]

x

 

x

   

1–5 (likert scale)

  1. Note: T0 = baseline measurement, T4, T9, (TS), T26, T52 are follow-up measurements at 4, 9, 26 and 52 weeks, respectively, after randomisation. Ts was received at the end of treatment, when treatment lasted longer than 9 weeks. MPI, Multidimensional Pain inventory; NDI, Neck Disability Index; SF-36, Short Form 36; EQ-5d, Euroquol 5-Dutch language version; TSK, Tampa Scale for Kinesiophobia; PCS, Pain Catastrophizing Scale; CES-D, Centre for Epidemiologic Studies – Depression; PSEQ, Pain Self-Efficacy Scale; PSOCQ, Pain Stages Of Change Questionnaire.